Compositions and methods for diagnosing or treating neutrophil-mediated inflammatory disease
US-2015004242-A1 · Jan 1, 2015 · US
US10254287B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10254287-B2 |
| Application number | US-201615216420-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 21, 2016 |
| Priority date | Jul 21, 2015 |
| Publication date | Apr 9, 2019 |
| Grant date | Apr 9, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed herein are stable and versatile protein nanoparticles having a range of tunable fluorescent properties. Such nanoparticles may find utility in biological imaging. Methods of synthesis of such nanoparticles are also disclosed.
Opening claim text (preview).
The invention claimed is: 1. A method of synthesizing a white-emitting protein fluorescent nanoparticle, the method comprising: labeling a protein by covalent linkage with at least three different fluorescent dye reagents selected from the group consisting of fluoresceins, rhodamines, coumarins, pyrenes, cyanines, squaraines, and boron-dipyrromethenes; and crosslinking the protein with a crosslinking agent, to thereby form the white-emitting protein fluorescent nanoparticle, wherein the secondary structure of the protein is retained, wherein the protein is labeled with the fluorescent dyes either before or after the crosslinking step. 2. The method of claim 1 , wherein the protein is labeled with the fluorescent dye reagent before the crosslinking step. 3. The method of claim 1 , wherein the protein is labeled with the fluorescent dye reagent after the crosslinking step. 4. The method of claim 1 , wherein the protein is selected from the group consisting of bovine serum albumin, glucose oxidase, horseradish peroxidase, catalase, lipase, hemoglobin, and lysozyme, and any combination thereof. 5. The method of claim 1 , wherein the crosslinking agent is 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide. 6. The method of claim 1 , wherein the three fluorescent dye reagents are selected from the group consisting of: 1-pyrenebutanoic acid N-succinimidyl ester; 7-methoxycoumarin-3-carboxylic acid N-succinimidyl ester; 7-diethylaminocoumarin-3-carboxylic acid N-succinimidyl ester; fluorescein isothiocyanate; tetramethylrhodamine-5-(and-6)-isothiocyanate; and 5(6)-carboxy-X-rhodamine N-succinimidyl ester. 7. The method of claim 1 , wherein the protein is bovine serum albumin, and the protein is labeled with three or four different fluorescent dye reagents selected from 7-methoxycoumarin-3-carboxylic acid N-succinimidyl ester, 7-diethylaminocoumarin-3-carboxylic acid N-succinimidyl ester, fluorescein isothiocyanate, and 5(6)-carboxy-X-rhodamine N-succinimidyl ester. 8. The method of claim 1 , wherein the nanoparticle has a diameter in a range of about 10 nm to about 100 nm. 9. The method of claim 1 , further comprising a step of annealing the nanoparticle by heating the nanoparticle to a temperature of about 80-90° C. for about 1-15 minutes. 10. The method of claim 1 , wherein the nanoparticle emits white fluorescence upon excitation at about 254 nm or at about 405 nm, and wherein the white fluorescence emission has chromaticity coordinates in which x is about 0.30 to about 0.40 and y is about 0.30 to about 0.40. 11. The method of claim 1 , further comprising a step of forming a metal nanocluster in the protein, either before or after the crosslinking step, wherein the metal is gold. 12. The method of claim 1 , further comprising labeling the nanoparticle with a biological compound. 13. The method of claim 12 , wherein the biological compound is selected from the group consisting of taurine and biotin. 14. The method of claim 1 , wherein the nanoparticle has a particle size of about 10 nm to about 100 nm. 15. A method of synthesizing a white-emitting protein fluorescent nanoparticle, the method comprising: labeling a protein by covalent linkage with at least three different fluorescent dye reagents; and crosslinking the protein with a crosslinking agent, to thereby form the white-emitting protein fluorescent nanoparticle, wherein the protein is labeled with the fluorescent dyes either before or after the crosslinking step, wherein the three fluorescent dye reagents are selected from the group consisting of: 1-pyrenebutanoic acid N-succinimidyl ester; 7-methoxycoumarin-3-carboxylic acid N-succinimidyl ester; 7-diethylaminocoumarin-3-carboxylic acid N-succinimidyl ester; fluorescein isothiocyanate; tetramethylrhodamine-5-(and-6)-isothiocyanate; and 5(6)-carboxy-X-rhodamine N-succinimidyl ester. 16. A method of synthesizing a white-emitting protein fluorescent nanoparticle, the method comprising: labeling a protein by covalent linkage with at least three different fluorescent dye reagents; and crosslinking the protein with a crosslinking agent, to thereby form the white-emitting protein fluorescent nanoparticle, wherein the protein is labeled with the fluorescent dyes either before or after the crosslinking step, wherein the protein is bovine serum albumin, and the protein is labeled with three or four different fluorescent dye reagents selected from 7-methoxycoumarin-3-carboxylic acid N-succinimidyl ester, 7-diethylaminocoumarin-3-carboxylic acid N-succinimidyl ester, fluorescein isothiocyanate, and 5(6)-carboxy-X-rhodamine N-succinimidyl ester.
Serum albumin, e.g. HSA · CPC title
Nanoparticles · CPC title
involving inorganic compounds or pH · CPC title
Nanoparticles · CPC title
with fluorescent label · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.